Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center

基因分型 外周血单个核细胞 干血斑 抗药性 基因型 逆转录酶 医学 病毒学 桑格测序 病毒载量 三级护理 聚合酶链反应 双腺苷 人类免疫缺陷病毒(HIV) 抗逆转录病毒药物 卡帕 核苷逆转录酶抑制剂 免疫学 生物 干血 套式聚合酶链反应 病毒 外周血 药品 艾滋病毒耐药性 分子生物学 内科学 齐多夫定
作者
P. Sabu,Diviya Alex,Veena Vadhini Ramalingam,John Paul Demosthenes,Gnanadurai John Fletcher,Priya Abraham,Rajesh Kannangai
出处
期刊:AIDS Research and Human Retroviruses [Mary Ann Liebert, Inc.]
卷期号:42 (2): 67-76
标识
DOI:10.1177/08892229251405793
摘要

The collection, storage, and transport of plasma, the ideal specimen for HIV-1 genotyping, is plagued by technical difficulties in resource-limited settings. We aimed to compare corresponding bio-samples for HIV-1 genotypic drug resistance testing. A total of 87 matched specimens of plasma, dried blood spots (DBS), and peripheral blood mononuclear cells (PBMCs) collected from 29 persons living with HIV (PLWH) in clinical, immunological, and/or virological failure were included. Drug resistance genotyping was done by nested PCR amplification and Sanger sequencing of the HIV-1 pol gene. The clinical reporting was based on the Stanford University HIV Drug Resistance Database. Amplification and genotyping success rates from the three sample types were compared. The level of agreement between the sample types was assessed using Cohen’s kappa coefficient. In total, 89.7% ( n = 26) of samples were amplified in plasma, 69% ( n = 20) in DBS, and 100% ( n = 29) in PBMC. In samples with plasma viral load >1,000 copies/mL, 96.2% were amplified in plasma, 73.1% in DBS, and 100% in PBMCs. The median number of mutations detected in plasma, DBS, and PBMCs was 6.5 (interquartile range [IQR]: 2–8.25), 5 (IQR: 0–6), and 5 (IQR: 2–7), respectively. The difference in the number of mutations across the three sample types was not statistically significant ( p = 0.221). The agreement between the sample types was calculated based on susceptibility and resistance to different antivirals. The kappa values for nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors ranged from 0.70 to 0.88 and 0.75 to 0.87, respectively. Six samples showed discordance in HIV-1 drug resistance profiles when compared across the three compartments. DBS is a promising alternative to plasma for HIV-1 genotypic testing in resource-limited settings owing to the ease of sampling, storage, transportation, human resource efficiency, and cost-effectiveness. However, no single specimen type can satisfy all requirements and purposes. Selecting an appropriate specimen for a setting requires careful consideration of the practical constraints, logistical capacity, and application needs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
许七安应助FF采纳,获得10
1秒前
湛无不盛完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
Dr_Fang发布了新的文献求助10
3秒前
3秒前
小冰糖发布了新的文献求助10
4秒前
啦啦啦完成签到,获得积分20
4秒前
5秒前
deng2025发布了新的文献求助10
6秒前
明明发布了新的文献求助10
6秒前
6秒前
ljz发布了新的文献求助10
7秒前
林木完成签到,获得积分20
7秒前
八九发布了新的文献求助10
8秒前
牛牛发布了新的文献求助10
9秒前
Li发布了新的文献求助10
9秒前
10秒前
11秒前
爆米花应助薛定谔的猫采纳,获得10
12秒前
霍霍发布了新的文献求助10
15秒前
默默完成签到 ,获得积分10
15秒前
虚幻孤丹发布了新的文献求助10
15秒前
知之发布了新的文献求助10
15秒前
mu发布了新的文献求助10
15秒前
安南完成签到 ,获得积分10
16秒前
lizishu应助寒冷的断秋采纳,获得10
16秒前
deng2025完成签到,获得积分20
17秒前
Dr_Fang完成签到,获得积分10
17秒前
酷波er应助科研通管家采纳,获得30
17秒前
初景应助科研通管家采纳,获得20
17秒前
CipherSage应助科研通管家采纳,获得10
17秒前
今后应助科研通管家采纳,获得10
18秒前
搜集达人应助科研通管家采纳,获得10
18秒前
Momomo应助科研通管家采纳,获得10
18秒前
无花果应助科研通管家采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Resiliency Scale for Adolescents--Chinese Version 600
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7320163
求助须知:如何正确求助?哪些是违规求助? 8935944
关于积分的说明 18943671
捐赠科研通 6978784
什么是DOI,文献DOI怎么找? 3214492
关于科研通互助平台的介绍 2382360
邀请新用户注册赠送积分活动 2193571